Disclosures for "Neuropsychiatric Profiles in Kleefstra Syndrome: Understanding Strengths and Vulnerabilities"
-
Dr. Pillai has nothing to disclose.
-
Ms. Frazier has nothing to disclose.
-
Dr. O'Donnell-Luria has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Addition Therapeutics. Dr. O'Donnell-Luria has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thiebaud Remington Thornton Bailey LLP. The institution of Dr. O'Donnell-Luria has received research support from Pacific Biosciences.
-
Mr. Katz has received personal compensation in the range of $0-$499 for serving as a Consultant for Novo Nordisk A/S.
-
Dr. Srivastava has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuren. Dr. Srivastava has stock in NVDIA. Dr. Srivastava has stock in TSLA. Dr. Srivastava has stock in GOOGL. Dr. Srivastava has stock in AMZN. Dr. Srivastava has stock in NFLX. Dr. Srivastava has stock in MSFT. Dr. Srivastava has received personal compensation in the range of $500-$4,999 for serving as a DSMB Chair with Rush.